3.48

3.87% -0.14

After Hours: 3.56 0.08 +2.30%

Bluejay Diagnostics Inc (BJDX)

Overview News Price History Financials Why BJDX Down? Discussions Forecast Stock Split

Bluejay Diagnostics Inc stock is traded at $3.48, with a volume of 19,500. It is down -3.87% in the last 24 hours and down -33.90% over the past month. Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Previous Close:

$3.62

Open:

$3.62

24h Volume:

19,500

Relative Volume:

0.06

Market Cap:

$1.91M

Revenue:

Net Income/Loss:

$-9.40M

P/E Ratio:

-0.3299

EPS:

-10.55

Net Cash Flow:

$-8.52M

1W Performance:

+1.16%

1M Performance:

-33.90%

6M Performance:

-98.22%

1Y Performance:

-99.72%

1-Day Range:

$3.2248

$3.65

1-Week Range:

$3.20

$3.9949

52-Week Range:

$3.03

$1,564.00

Bluejay Diagnostics Inc Stock (BJDX) Company Profile

Name

Bluejay Diagnostics Inc

Sector

Healthcare (1200)

Industry

Medical Devices (153)

Phone

(978) 631-0152

Address

360 MASSACHUSETTS AVENUE, SUITE 203, ACTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BJDX's Discussions on Twitter

Compare BJDX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BJDX Bluejay Diagnostics Inc	3.48	1.91M	0	-9.40M	-8.52M	-10.55
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Bluejay Diagnostics Inc Stock (BJDX) Latest News

Nov 21, 2024

Bluejay Diagnostics Implements 1-for-50 Reverse Stock SplitBluejay Diagnostics, Inc. (NASDAQ: BJDX) recently announced a significant development in its corporate structure with the completion of a reverse stock split. The decision for the reverse sto - Defense World

Nov 21, 2024

Nov 15, 2024

Anson Funds Management LP Increases Stake in Bluejay Diagnostics Inc - GuruFocus.com

Nov 15, 2024

Bluejay Diagnostics board approves reverse stock split - Medical Buyer

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Bluejay Diagnostics Inc - GuruFocus.com

Nov 15, 2024

Bluejay Diagnostics stock plunges to 52-week low of $0.07 - Investing.com India

Nov 15, 2024

Nov 14, 2024

Bluejay Diagnostics stock plunges to 52-week low of $0.07 By Investing.com - Investing.com Canada

Nov 14, 2024

Nov 13, 2024

Bluejay Diagnostics Announces Reverse Stock Split - citybiz

Nov 13, 2024

Bluejay Diagnostics announces 1 for 50 reverse stock split - MSN

Nov 13, 2024

Bluejay Diagnostics Implements 1-for-50 Reverse Stock Split, Reduces Shares to 552K | BJDX Stock News - StockTitan

Nov 13, 2024

Nov 12, 2024

DXCM Stock Surges Over 5% Amid Strong Financials and Positive An - GuruFocus.com

Nov 12, 2024

Nov 06, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Nov 06, 2024

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Nov 06, 2024

Nov 05, 2024

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.88% - MSN

Nov 05, 2024

U.S. Stock market: Bluejay Diagnostics (+105.33%), Zoomcar Holdings (+180.40%), and Verrica Pharmaceuticals(+39.10%) among the most volatile stocks during mid day trading - Business Upturn

Nov 05, 2024

Does Bluejay Diagnostics Inc (NASDAQ: BJDX) Still Look Hot This Week? - Stocks Register

Nov 05, 2024

Nov 01, 2024

BJDX stock touches 52-week low at $0.08 amid sharp annual decline - Investing.com Australia

Nov 01, 2024

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America - Marketscreener.com

Nov 01, 2024

Buejay Diagnostics, Inc Announces Results from the Primary Analysis of SYMON-I - Marketscreener.com

Nov 01, 2024

Oct 27, 2024

Short Interest in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Grows By 300.8% - Defense World

Oct 27, 2024

Oct 25, 2024

Bluejay Diagnostics shareholders approve reverse stock split - Investing.com India

Oct 25, 2024

Oct 24, 2024

Bluejay Diagnostics shareholders approve reverse stock split By Investing.com - Investing.com UK

Oct 24, 2024

Oct 19, 2024

Bluejay Diagnostics Inc’s (BJDX) -5.05% Retreat Justifies A Second Look - Stocks Register

Oct 19, 2024

Oct 16, 2024

Bluejay Diagnostics adjusts stockholder meeting quorum By Investing.com - Investing.com South Africa

Oct 16, 2024

Bluejay Diagnostics adjusts stockholder meeting quorum - Investing.com India

Oct 16, 2024

Bluejay Diagnostics stock hits 52-week low at $0.1 - Investing.com

Oct 16, 2024

Bluejay Diagnostics stock hits 52-week low at $0.1 By Investing.com - Investing.com UK

Oct 16, 2024

The Potential Rise in the Price of Bluejay Diagnostics Inc (BJDX) following insiders activity - Knox Daily

Oct 16, 2024

Oct 15, 2024

An analyst sees good growth prospects for Bluejay Diagnostics Inc (BJDX) - SETE News

Oct 15, 2024

Oct 14, 2024